Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common pediatric cancers and among the leading causes of death in children.

To improve kids’ chances of survival, early diagnosis and prompt hospital treatment are required. ALL also requires numerous outpatient visits for consistent oral medication. The problem is getting access to such care is much harder for families in some neighborhoods and small towns, according to new research by UC San Francisco.

A recent study by USC researchers reveals that nicotine pouch usage among U.S. high school students nearly doubled from 2023 to 2024, with 5.4% of teens reporting use in 2024 compared to 3.0% in 2023. This rise, particularly among male, non-Hispanic white, and rural teens, highlights a growing public health concern, prompting calls from organizations like the American Heart Association for increased regulation. Experts emphasize the need for targeted prevention strategies as the long-term health effects of these products remain largely unknown.

Recently approved Alzheimer’s drugs offer a step forward for treating the disease, but new therapeutic strategies are needed to complement them and provide personalized therapeutic approaches. Mass General Brigham researchers have identified a potential strategy to protect against Alzheimer’s disease by increasing the clusterin protein (CLU).